Synchronous or Staged Carotid Endarterectomy and Coronary Artery Bypass Grafting? Propensity score matched study

Sebastian Hempe1, Ajay Moza, Andreas Goetzenich

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital RWTH Aachen, Pauwelsstrasse 30, Aachen 52074, Germany.

The Heart Surgery Forum
|October 13, 2018
PubMed

Insights

The staged approach for coronary artery bypass graft (CABG) and carotid endarterectomy (CEA) surgery may lead to fewer postoperative neurological complications and respiratory issues compared to synchronous procedures. Further randomized studies are needed to confirm these findings for optimal patient care.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Clinical Outcomes Research

Background:

  • Optimal treatment strategy for patients with significant carotid artery disease undergoing cardiac surgery is debated.
  • Retrospective analysis of synchronous versus staged coronary artery bypass graft (CABG) and carotid endarterectomy (CEA) procedures.

Purpose of the Study:

  • To compare the outcomes of synchronous versus staged CABG and CEA procedures.
  • To evaluate the incidence of perioperative stroke, transient ischemic attack, and other complications.

Main Methods:

  • Retrospective analysis of 323 patients undergoing synchronous (N=307) or staged (N=16) CABG and CEA between 2011-2016.
  • Propensity score matching (1:2) used to compare staged patients with synchronous patients (synchronousmatched).
  • Collection and analysis of patient characteristics, perioperative, and postoperative data.

Main Results:

  • Overall incidence of ischemic stroke (IS) was 4.9% and transient ischemic attack (TIA) was 5.6%.
  • No significant difference in IS incidence between matched groups (P=1.000).
  • Significantly higher rates of TIA (P=.041), delirium (P=.043), and respiratory insufficiencies (P=.043) in the synchronousmatched group compared to the staged group. 30-day mortality showed no significant difference.

Conclusions:

  • Findings suggest a potential superiority of the staged CABG/CEA approach.
  • Higher rates of postoperative neurological and respiratory complications observed in the synchronous group.
  • Large, randomized trials are necessary to validate these findings and establish clinical guidelines.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
411